Diligence memo · auto-generated · as of July 3, 2026
XOStem Biosciences Ltd.
XOStem Biosciences Ltd. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
XOStem Biosciences Ltd. operates in Biotech / Pharma, based in IRVINE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
XOStem Biosciences Ltd. has raised $3.3M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $892K on 2022-10-07.
Most recent recorded round closed around 2024-02-16.
Valuation (modeled)modeled
Provath models XOStem Biosciences Ltd. at approximately $2.2M (range $207K–$8.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.03× the median modeled value of Pre-Seed Biotech / Pharma companies in 2022–2024 (28 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 2.4 yr ago; this sector typically re-raises about every 15 months.
Slightly overdue versus sector cadence.
The last round was 2.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 44% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 16% of those peers.
Closest niche peers: Gaingels Oct Bio LLC, Gaingels Alto Pharmacy LLC, Pyros Pharmaceuticals, Inc., Allander Biotechnologies, Inc., CyMon Bio, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.